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Abstract
Background: Sortin2 is a low mass compound that interferes with vacuolar delivery of proteins
in plants and yeast. The Sortin2 phenotype was tested in Arabidopsis thaliana and found to be
reversible upon drug removal, demonstrating the ability of chemical genomics to induce reversible
phenotypes that would be difficult to achieve using conventional genetics [1]. However, standard
genetic methods can be used to identify drug target pathways in a high-throughput manner.
Results: In this study, we analyzed structure-function relationships of Sortin2 using structural
analogues. The results show the key roles of sulphite substitution and a benzoic acid group. A
Sortin 2 hypersensitivity screen for the induced secretion of a vacuolar cargo protein was done
utilizing a yeast haploid deletion library. Using bioinformatics approaches, we highlighted functional
information about the cellular pathways affected by drug treatment which included protein sorting
and other endomembrane system-related processes.
Conclusion: Chemical, genomic and genetics approaches were used to understand the mode of
action of Sortin2, a bioactive chemical that affects the delivery of a vacuolar protein. Critical
features of Sortin2 structure necessary for bioactivity suggest a binding pocket that may recognize
two ends of Sortin2. The genome-wide screen shows that Sortin2 treatment in yeast affects
primarily components within the endomembrane system. This approach allowed us to assign
putative functions in protein sorting for fifteen genes of previously unknown function.
Background
Endomembrane trafficking in eukaryotes is essential for
the intracellular delivery of cargoes and membranes. As
the site of protein degradation, nutrient recycling and
storage of biological components, the vacuole is one of
the key compartments of the endomembrane system. In
addition, the mechanisms implicated in the delivery of
cargoes to the vacuole have been delineated mainly by
yeast genetic screens. A relatively new approach for dis-
covering cellular pathways that takes advantage of yeast
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genetics is chemical genomics, which uses small bioactive
molecules that can affect biological pathways [2,3]. The
physiological effects of such drugs may be appreciated
and exploited long before the corresponding targets are
identified. However, the eventual identification of target
proteins within drug-sensitive pathways is necessary to
discover and characterize intracellular networks [4-10].
Using forward chemical genomics, we identified fourteen
low mass compounds that interfere with the delivery of
the vacuolar resident protein carboxypeptidase Y (CPY) in
Saccharomyces cerevisiae [1]. These compounds are able to
trigger the secretion of CPY, mimicking the vacuole protein
sorting (vps) phenotype [11]. Two of these compounds,
Sortin1 and Sortin2, result in the secretion of CPY in Ara-
bidopsis thaliana [1]. To understand Sortin2 activity in
more detail, we focused on two objectives: to understand
the structural features of Sortin2 necessary for its activity
and to analyze S. cerevisiae cellular pathways affected by
the chemical. The bioactivity of different Sortin2 ana-
logues highlighted structural domains important for
Sortin2 activity. In order to identify the cellular path-
way(s) affected by Sortin2, a genetic screen was performed
for strains hypersensitive to this chemical in a S. cerevisiae
haploid deletion collection. Among 4,800 clones
screened, 217 strains were hypersensitive to Sortin2. Bio-
informatics analysis indicated that the Sortin2 dataset was
enriched in components related to protein trafficking and
localized primarily to the endomembrane system, partic-
ularly endosomes. Our approach permitted an initial
functional assignment of fifteen genes of previously
unknown function to protein trafficking pathways.
Results
Carboxypeptidase Y (CPY) is a soluble vacuolar hydrolase
that is sorted from the late Golgi to the late endosome and
subsequently trafficked to the vacuole [12-14]. In yeast,
Sortin2 interfered with CPY sorting resulting in secretion
to the media [1]. Sortin2 also phenocopied vps mutants
without inhibiting yeast growth, at concentrations rang-
ing from 4.7 µM to 47 µM (Fig 1a and 1b). Upon Sortin2
treatment, there was no detectable presence in the
medium of the proteins such as alkaline phosphatase
(ALP), a membrane-bound vacuolar protein, or 3-phos-
phoglycerate kinase, a cytoplasmic protein (Fig. 1a). These
controls indicated that CPY in the medium of Sortin2-
treated cells was not due to cell lysis. The total amount of
expressed CPY protein was not significantly affected by
Sortin2 treatment indicating that its secretion was due to
an alteration in cargo delivery rather than simple over-
loading of endomembrane compartments (Fig 1c). There-
fore, we concluded that Sortin2 targeted components
involved in the delivery of CPY from the endoplasmic
reticulum to the vacuole.
Sortin2 structure-bioactivity relationships
In order to understand the structural determinants of Sor-
tin 2 necessary for bioactivity, a panel of chemicals that
were similar in structure to Sortin2 were examined. The
Sortin2 contains discrete domains: a chlorobenzene, a
furan, a thiazolidine ring, and a sulphite group. The activ-
ity of structural analogs as promoters of CPY secretion is
shown in Figure 2. For convenience, the potency of Sortin
2 and its analogues was defined as the minimum concen-
tration at which activity was observed.
Chemical  1  (Fig. 2) represented the Sortin2 structure
minus the sulphite group. This analogue was inactive
indicating that the sulphite group was critical for binding
of Sortin2 to its target. Chemical 2 which had a benzoic
ring substitution instead of the sulphite group had the
same activity as Sortin2. Chemical 3 had a carboxyl group
instead of the sulphite group. It was bioactive; however, it
had a lower potency (40 µM) than Sortin2 and chemical
2 (5 µM). Taken together, these data suggest that the inter-
action between Sortin2 and its target probably required a
dense electron cloud in order to affect target activity and
function. This could be direct or indirect by affecting the
overall conformation of Sortin2.
Chemical 4 lacked the chlorobenzene ring, but did not
alter the delivery of CPY to the vacuole. We further tested
the importance of the chlorine on the benzene ring by
testing another chemical (5) which had a nitro group sub-
stitution. Chemical 5 was twenty times less active than
Sortin2 which indicated that the presence of the chloride
was important for full activity. However, chemical 6, in
which the chloride was absent showed a potency that was
similar to that of chemical 5 supporting the notion that
the halogen atom was not a key feature for bioactivity.
Chemical 7 which had two chlorides associated with the
benzoic group was completely inactive, perhaps due to
steric effects. Steric hindrance may also explain the low
activity of chemical 5 since the major difference was the
chloride and nitro groups. Overall we concluded that the
sulphite group and the benzoic acid ring were essential for
Sortin2 bioactivity.
Screening for yeast mutants hypersensitive to Sortin2
In order to identify cellular pathways affected by Sortin2 a
haploid yeast deletion library was screened for mutants
that secreted CPY at concentrations of Sortin2 that did not
trigger detectable CPY secretion in the wild type haploid
strain. Of the collection of 4,800 strains, 243 putative
hypersensitive mutants were identified in the primary
screen (Fig. 3a). Each putative mutant was subsequently
exposed to various concentrations of Sortin2 to verify the
drug dependency of their secretion phenotype (Fig. 3b). A
mutant was considered verified as hypersensitive if signif-
icant CPY secretion was detected at a concentration ofBMC Chemical Biology 2008, 8:1 http://www.biomedcentral.com/1472-6769/8/1
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Sortin2 less than that necessary to result in CPY secretion
from the parental line (Fig. 3b). Ninety percent (217) of
the strains were verified as hypersensitive to Sortin 2. The
large number of successfully verified strains demonstrated
the robustness of the primary screen.
Vacuolar protein sorting (vps) mutants and 
hypersensitivity to Sortin2
Sixty-one yeast deletion strains were known previously to
have impaired sorting of CPY; these are referred to as vps
mutants. Forty-one vps mutants were identified as drug-
dependent in our screen with respect to Sortin2. These
included mutants in all six classes of VPS genes (Addi-
tional file 1). Class E is involved in protein sorting to
lumenal vesicles of the MVB (multi-vesicular body). This
family contains 16 members plus VTA1 and HSE1; how-
ever, the latter two genes were not described as VPS genes
[11]. Remarkably, fourteen out of sixteen members
(88.9%) of the VPS Class E were hypersensitive to Sortin2,
the class with highest representation among VPS genes.
Interestingly, the remaining 20 vps mutants displayed no
secretion of CPY when treated with Sortin2. The screen,
thus, discriminated between deletion and Sortin2-
induced vps phenotypes. This indicated that the Sortin2
phenotype was specific and distinct, rather than a broad
effect on secretion, when compared to the majority of the
vps mutants. As part of this screen, we analyzed the drug
sensitivity of 148 strains identified previously in a screen
for mutants that secreted CPY [15]. Among these mutants,
91 were hypersensitive to Sortin2 when compared to the
untreated control. The absence of a hypersensitive
response from the other 57 mutants indicated that Sortin2
was selective for specific elements of the vacuole targeting
machinery.
Analyses of identified ORFs
FunCat [16] was used to classify the Sortin2 hypersensi-
tive dataset into functional categories relative to the Sac-
charomyces genome (Table 1, Additional file 2). Some
categories showed statistically significant over-representa-
tion such as "interaction with the environment" and "bio-
genesis of cellular components" which were enriched 1.7-
Structure-activity relationship of Sortin2 structural analogs Figure 2
Structure-activity relationship of Sortin2 structural analogs. 
The ability to trigger secretion of CPY was tested for all 
compounds shown. Compounds are referred by the identifi-
cation numbers assigned by manufacturer.
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Effects of Sortin2 treatments on S. cerevisiae Figure 1
Effects of Sortin2 treatments on S. cerevisiae. (A) Dot-blot 
secretion assay using monoclonal antibodies raised against 
CPY, alkaline phosphatase (ALP) and 3-phosphoglycerate 
kinase (PGK). (B) Yeast growth in presence of 1% DMSO 
(● ), 2 µg/ml (4.7 µM) Sortin2 () and 20 µg/ml (47 µM) 
Sortin2 (■ ). (C) Western blot using CPY antibody of cell 
fractions of yeast upon 1% DMSO (1), 2 µg/ml (4.7 µM) 
Sortin2 (2) and 20 µg/ml (47 µM) Sortin2 (3) treatment.
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and 1.5-fold, respectively (p ≤ 0.04) (Table 1). The great-
est enrichment were the categories "protein fate" and "cel-
lular transport, transport facilities and transport routes"
which displayed 2.5- and 3-fold enrichment, respectively
(p = 1.51 E-19 and 2.99 E-29; Table 1). In terms of subcel-
lular location, the greatest over-representation corre-
sponded to the category "endosomes" with a 17.5-fold
enrichment compared to the yeast genome (p = 6.2 E-35)
(Table 1). The "Golgi apparatus", "transport vesicles",
"vacuole" and "punctuate composite" categories were
enriched between 3.5- and 5.4-fold with statistically sig-
nificant over-representation as shown by the p-values in
Table 1. These results revealed that processes within the
endomembrane system are strongly and specifically
affected by Sortin2 treatment.
Forty-seven percent of the Sortin2 dataset was associated
with the GO term "Transport". The set was analyzed by
Term Finder tools, and significantly, the sole descendant
terms included "Protein Transport", "Intracellular Trans-
port", "Vesicle-mediated Transport" and "Secretory Path-
way" highlighting the involvement of the majority of
identified ORFs in protein trafficking pathways (data no
shown). We also applied the Term Finder tool to analyze
the association of the Sortin2 dataset with granular GO
terms that were linked to a cellular component (Addi-
tional file 3). Within the Sortin2 hypersensitive dataset,
Identification of Sortin2 hypersensitive mutants Figure 3
Identification of Sortin2 hypersensitive mutants. (A) Primary screen: 4827 haploid deletion strains were challenged with 1% 
DMSO (DMSO) or Sortin2 at 2 µg/ml (4.7 µM) (Sortin2). Culture media was analyzed for the presence of CPY by dot blot 
assay. Clones secreting significant amounts of CPY compared to the negative control were selected as putative mutants. The 
arrowheads show the primary hits. (B) Secondary screen: 243 putative mutants were tested on DMSO and varying concentra-
tions of Sortin2. Threshold was defined as the concentration of Sortin2 that had no residual CPY secretion on a wild type 
parental line (wt, 2 µg/ml). For CPY secretor strains, the strain was considered as hypersensitive to Sortin2 if the CPY secre-
tion in the presence of Sortin2 was in excess of that displayed in the presence of DMSO. Different scenarios are shown as 
examples of the secondary screen results: a false positive strain (mam1), a Sortin2 hypersensitive strain (ubp3), and two Sortin2 
hypersensitive strains secreting CPY on control conditions (hur1 and vps55).
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we identified members of crucial Golgi and endosomal
sorting complexes, their interacting partners and other
resident proteins associated all directly in CPY sorting
(Additional file 3). In the endosomal compartment,
which is the destination for CPY after exiting the late
Golgi, we identified members of the three known endo-
somal and the MVB sorting complexes. Systematic dele-
tion of ESCRT (Endosomal Sorting Complex Required for
Transport) genes was reported to cause reduced telomere
length [17]. Interestingly, we identified ESCRT-unrelated
telomere length mutants as hypersensitive in our screen.
In addition several mutants linked to chromatin remodel-
ling were identified (Additional file 3). Overall, we con-
cluded that the Sortin2 hypersensitive ORFs were located
preferentially within the endomembrane system and
included many molecular components related to the CPY
delivery. Our screening results also supported the hypoth-
esis previously proposed that interactivity occurs between
the endomembrane system, chromatin remodelling, and
telomere maintenance processes.
Importantly, the sublethal conditions of the screening
assay yielded an unbiased set of mutants. The dataset did
not include any ABC transporters or ergosterol biosyn-
thetic genes which are related to multi-drug resistance
[18] suggesting that the screen distinguished between
induced vps phenotypes and general drug sensitivity.
Unknown genes
Of 217 Sortin2 hypersensitive mutants, 30 were classified
as unknown according to the SGD databases. Among
these ORFs, several were dubious genes with known genes
on the complementary DNA strand. It is also possible that
the Sortin2 phenotype resulted from a defect in an
authentic gene whose ORF overlapped the dubious ORF.
These dubious genes are listed with their corresponding
known ORFs in parenthesis in Table 2. YIP4 encodes a
protein that mediates vesicular trafficking via its interac-
tion with Rab GTPases [19] supporting the dubious char-
acter of YGL199C. Similarly, Gim5p is a member of a
protein complex that promotes formation of functional α-
and γ-tubulin [20]. This complex includes Gim4p that was
identified in our screen; thus YML094C-A is probably a
dubious ORF.
Other unknown genes were found in high-throughput
screens that focused on genetic/physical interactions and
protein localization [21-23]. This annotation supports
putative roles for the corresponding gene products in pro-
tein trafficking. Ygr206wp, for example, was identified as
endosomal and more recently as a component of the
ESCRT-1 complex [23-25]. YGR206wp and Ylr426wp
physically interact with the V-ATPase subunit Vma6p [21].
Their corresponding genes together with YNL080C, SNA2
and TMS1 were the only uncharacterized ORFs from our
dataset that overlapped previously unknown genes whose
deletion resulted in CPY secretion [15]. Excluding the 10
dubious ORFs described above, the remaining 15
unknown genes have not been associated previously with
protein sorting pathways. Among these unknowns,
Yil041wp (Gvp36p) was localized to Golgi vesicles [26].
The mutants for the unknown ORFs YDR357C  and
YGL079W were hypersensitive to Sortin2 and their gene
products were identified as interacting partners in a two-
hybrid assay [22]. The GFP fusion of Ygl079wp co-local-
izes with an endosome marker [23]. In addition,
Ydr357cp and Yll049wp, both from the Sortin2 dataset,
physically interact with the autophagy protein Atg17p
Table 1: Functional and locational gene product categorization of Sortin2 hypersensitive ORFs.
Representation on dataset Enrichment on dataset (-fold)
Sortin2 Genome p-value
FUNCTIONAL CATEGORY
Cellular transport, transport facilities and transport routes 50.7 16.9 2.99 E-29 3.0
Protein fate (folding, modification, destination) 46.2 18.8 1.51 E-19 2.5
Biogenesis of cellular components 21.3 14 0.003 1.5
Interaction with the environment 12.9 7.55 0.004 1.7
LOCATIONAL CATEGORY
Endosome 16.4 0.94 6.2 E-35 17.5
Golgi 13.9 2.57 1.0 E-13 5.4
Transport vesicles 11.4 2.29 1.1 E-10 5.0
Punctate composite 8.95 2.29 6.3 E-07 3.9
Vacuole 16.4 4.63 1.1 E-10 3.5
ER 15.9 9.1 0.0011 1.8
Category representation of the abundance within Sortin2 hypersensitive (201 genes) and the Saccharomyces genome (6131 genes). P-value was 
calculated using hypergeometric distribution as statistical test. P-values < 0.0005 were considered as statistical significant.BMC Chemical Biology 2008, 8:1 http://www.biomedcentral.com/1472-6769/8/1
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[21] suggesting a role in the endomembrane system. Sim-
ilarly, YIL039W and YLR361C (DCR2) genetically interact
with the Golgi residents Ric1p and Ypt6p [27], both of
which mediate vesicular trafficking at the Golgi apparatus.
Tvp38p (Figure 3b) is an integral membrane protein local-
ized to late Golgi vesicles along with the v-SNARE Tlg2p
[26].
To test the interaction of mutants in unknown ORFs with
Sortin2, active and inactive analogues were tested for their
ability of trigger CPY secretion in the corresponding dele-
tion mutants for YDR525W-A/SNA2, YDR105C/TMS1,
YGL079W, YLL049W, YKR088C/TVP38 (data no shown).
All of the mutants were more hypersensitive compared to
their parental strain when grown in the presence of bioac-
tive compounds 2 and 5. In contrast, none of the strains
tested were hypersensitive to the inactive Sortin2 ana-
logues 1, 4 and 7. Therefore, the Sortin2 hypersensitivity
of mutants in these genes of unknown function was spe-
cific for analogues possessing features important for
Sortin2 bioactivity. There were no detectable ALP or PGK
proteins in the culture media for any Sortin2 analogs
(data no shown) indicating that the CPY secretion was not
due to the cell lysis.
In summary, we assigned a putative role in protein traf-
ficking to 15 ORFs of unknown function in S. cerevisiae
based on their Sortin2-induced vps phenotypes. The actual
role of these ORFs will be addressed in future studies.
Discussion
In this study, we analyzed the structure-activity relation-
ships and the cellular pathways affected by Sortin2 which
triggers the secretion of the soluble vacuolar protein CPY
in S. cerevisiae and A. thaliana. Our Sortin2 hypersensitive
screen identified genes whose loss of function resulted in
no vacuolar sorting defects; however, a sorting defect
occurred when these mutants were challenged with the
drug.  Furthermore, our analysis implicated a number of
genes of unknown function in the process of vacuolar pro-
tein sorting. Therefore, this approach could be of general
use for discovering the functional identity of uncharacter-
ized genes.
The use and analysis of Sortin2 structural analogs allowed
us to define the sulphite substitution and benzoic acid
group on Sortin2 as key determinants for bioactivity and
perhaps target binding. Interaction with a target would
probably require both ends of the molecule suggesting a
binding pocket that recognizes one face of Sortin2. How-
ever, the possibility of multiple binding pockets or targets
can not rule out. It is possible to speculate that the dimen-
sions of the binding pocket in the cognate target are very
exacting for activity resulting in lower potency or no activ-
ity as observed for several Sortin2 analogs. The com-
pounds tested are within the parameters set by Lipinski
[28] indicating that compound permeability would not
be an issue.
We screened for enhanced secretion in the presence of
Sortin2 using a haploid deletion library. If the drug has a
single target, deletion of the gene encoding the target
would result in a strain whose phenotype could not be
enhanced further by the drug. Thus, our approach would
not identify a cognate target. However, we anticipated that
this hypersensitive screen would identify proteins that
were either in the same pathway or in a pathway con-
nected to the Sortin2 target. The main pathway affected by
Sortin2 is the endomembrane system although the effect
could be indirect. The intracellular location displaying the
greatest enrichment was the endosomes suggesting that
the Sortin2 target may be affecting mainly the endosomal
compartments which precede the final localization of
CPY. Consistent with this idea, almost 90% of the vps
Table 2: Unknown function ORF of the corresponding deletion 
strains identified as Sortin2 hypersensitive mutants.
Unknown genes categories ORF
Dubious YGR064W (SPT4)
YDL096C (PMT1)
YNR005C (VPS27)
YOR331C (VMA4)
YPR050C (MAK3)
YDR455C (NHX1)
YML012C-A (SEL1)
YKR035C (DID2)
YGL199C (YIP4)
YML094C-A (GIM5)
YOL079W (REX4)
CPY secretor deletion strain YLR426W
YNL080C
YDR525W-A/SNA2
YDR105C/TMS1
Not previously associated to sorting pathway YCL075W
YCR095C
YDR357C
YGL079W
YIL039W
YIL041W/Gvp36p
YIL130W/ASG1
YJL077C/ICS3
YKR088C/TVP38
YLL049W
YLR361C/DCR2
YMR158C-B
YMR315W
YNL063W/MTQ1
YOL111C
The name in parenthesis correspond to the known gene on the 
complementary DNA strain of dubious genesBMC Chemical Biology 2008, 8:1 http://www.biomedcentral.com/1472-6769/8/1
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Class E mutants, which have an aberrant MVB (the "Class
E compartment"), were hypersensitive to Sortin2. Sortin2
is able to mimic the vps phenotype; however, its effect on
MVB structure has not been tested yet.
Sortin2 will be useful for probing conserved processes
such as endomembrane trafficking in other organisms,
and the powerful genomics available will permit the iden-
tification of cognate targets.
Conclusion
In this study, we combined chemical, genomic and genet-
ics approaches to understand the mode of action of
Sortin2, a bioactive chemical that affects the delivery of a
vacuolar protein. Several features of Sortin2 structure are
critical for bioactivity suggesting a binding pocket that rec-
ognizes one face of the molecule.
The genome-wide screen in yeast showed that Sortin2
mainly affected components within the endomembrane
system. Other cellular functions affected by Sortin2 may
highlight interactions between cellular processes. Our
approach allowed us to assign a putative function in pro-
tein sorting for 15 genes of unknown function that were
not associated previously with protein trafficking path-
ways.
Methods
Protein secretion assay
The BY4742 haploid parental line (MATalpha his3∆1
leu2∆0 lys2∆0 ura3∆0) was grown in yeast extract/pep-
tone/dextrose (YPD) medium supplemented with the des-
ignated compounds or 1% DMSO as a negative control.
Cultures were grown for 72 hours at 30°C. Growth
medium was analyzed using monoclonal antibodies
against CPY, ALP and 3-phosphoglycerate kinase (Molec-
ular Probes) by dot-blot as described previously [1].
Sortin2 analogs and substructures
Sortin2 and its analogues and substructures were obtained
from Chembridge (San Diego, CA) and referred to by the
identification numbers assigned by the manufacturer.
Analogue and substructure searches were done using the
Hit2Lead database (Chembridge), SciFinder database,
and the ChemMine comparative chemical database
[29,30].
Sortin2 Hypersensitivity Screening
The S. cerevisiae haploid deletion library was generated
using the BY4742 parental strain containing 4,800 yeast
clones (Open Biosystems, Huntsville, AL). The primary
screen utilized the microplate format of the deletion
library. The library was grown on 2 mg/l (4.7 µM) Sortin2
and 1% DMSO. Growth medium was analyzed for
secreted CPY as described previously [1]. The mutant
strains identified in the primary screen were further ana-
lyzed for CPY secretion at various concentrations of
Sortin2 (0.5, 1, 2, 5, and 10 mg/l) in a verification screen.
Mutants were considered verified as hypersensitive if sig-
nificant CPY secretion was detected at 2 mg/l of Sortin2.
Bioinformatics analyses
The Functional Categorization (FunCat) and Cellular
Location (CellLoc) of the identified genes were acquired
form The Munich  Information Center for Proteins
Sequences [31]. To retrieve information about each
deleted ORF, we queried the Saccharomyces Genome
Database (SGD, [32]). The SGD tools were also used to
assign the granular or general Gene Ontology (GO) terms
to identified ORFs, using the GO Term Finder or the GO
Slim Mapper, respectively.
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